| Design, synthesis and biological evaluation of new aryl thiosemicarbazone as antichagasic candidates L Blau, RF Menegon, GHG Trossini, JVD Molino, DG Vital, RMB Cicarelli, ... European journal of medicinal chemistry 67, 142-151, 2013 | 50 | 2013 |
| An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors FHA Leite, TQ Froes, SG da Silva, EIM de Souza, DG Vital-Fujii, ... European journal of medicinal chemistry 132, 322-332, 2017 | 27 | 2017 |
| Fragment‐based drug discovery as alternative strategy to the drug development for neglected diseases JFR Mello, RA Gomes, DG Vital‐Fujii, GM Ferreira, GHG Trossini Chemical biology & drug design 90 (6), 1067-1078, 2017 | 21 | 2017 |
| Application of bioisosterism in design of the semicarbazone derivatives as cruzain inhibitors: a theoretical and experimental study DG Vital, FS Damasceno, LN Rapado, AM Silber, FS Vilella, RS Ferreira, ... Journal of Biomolecular Structure and Dynamics 35, 1244-1259, 2017 | 18 | 2017 |
| Synthesis, leishmanicidal activity, structural descriptors and structure–activity relationship of quinoline derivatives EJG Silva, A Bezerra-Souza, LFD Passero, MD Laurenti, GM Ferreira, ... Future Medicinal Chemistry 10, 2069-2085, 2018 | 12 | 2018 |
| Molecular modeling and docking application to evaluate cruzain inhibitory activity by chalcones and hydrazides D Gomes Vital, M Arribas, G Henrique Goulart Trossini Letters in Drug Design & Discovery 11 (3), 249-255, 2014 | 12 | 2014 |
| The Role of QSAR and Virtual Screening Studies in Type 2 Diabetes Drug Discovery SQ Pantaleão, DGV Fujii, VG Maltarollo, DDC Silva, GHG Trossini, ... Medicinal Chemistry 13 (8), 706-720, 2017 | 11 | 2017 |
| Progress in the photodynamic therapy treatment of Leishmaniasis DG Vital-Fujii, MS Baptista Brazilian Journal of Medical and Biological Research 54, 2021 | 10 | 2021 |
| Antiplasmodial activity of sulfonylhydrazones: in vitro and in silico approaches F Moura Gatti, RA Gomes, AL da Fonseca, EJ Cardoso Lima, ... Future Medicinal Chemistry 13 (03), 233-250, 2021 | 1 | 2021 |
| Antiplasmodial activity of sulfonylhydrazones: in vitro and in silico approaches. RA Gomes, AL da Fonseca, CL EJ, DG Vital-Fujii, AG Taranto, GT GH Future Medicinal Chemistry, 2020 | | 2020 |
| Aplicação de planejamento baseado na estrutura do receptor na busca de inibidores de cisteíno-proteases parasitárias (cruzaína (T. cruzi) e PCB (Leishmanioses) DGV Fujii UNIVERSIDADE DE SÃO PAULO, 2018 | | 2018 |
| Molecular dynamic simulation and pharmacophore model of parasitic cysteine proteases DG Vital Fujii, GM Ferreira, JF Rezende e Mello, G Trossini ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017 | | 2017 |
| Construction and validation of the CPB2. 8 model and pharmacophore model design of cysteine proteases DGV Fujii, GM Ferreira, JFR Melo, GHG Trossini Proceedings, 2017 | | 2017 |
| Construção e validação da cisteíno-protease de L. mexicana (CPB2. 8) como alvo bioquímico no planejamento de fármacos DG Vital, VG Maltarollo, GHG Trossini Resumos, 2015 | | 2015 |
| Nitrofurazone bioisosters (semicarbazone, thiosemicarbazone and aminoguanidine derivatives) as antichagasic candidates DG Vital, VG Maltarollo, F Damasceno, LN Rapado, AM Silber, FS Vilella, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 248, 2014 | | 2014 |
| Synthesis, molecular modeling and docking studies of nitrofurazone analogues as trypanomicine candidates DG Vital, GHG Trossini Brazilian Journal of Pharmaceutical Sciences 49, 10 res. SDD016, 2013 | | 2013 |
| Planejamento, síntese e avaliação biológica de análogos bioisostéricos da nitrofurazona: variações de anéis (pirrol e 4-dimetilaminobenzil) e cadeias laterais (semicarbazona … DG Vital Universidade de São Paulo, 2013 | | 2013 |
| Stereoeletronic molecular modeling studies by chalcones and hydrazides as antichagasic candidates DG Vital, EI Ferreira, GHG Trossini Brazilian Journal of Pharmaceutical Sciences 48, 30 res. FCF056, 2012 | | 2012 |
